Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.8200
-0.1353 (-14.16%)
At close: Nov 20, 2026, 4:00 PM EST
0.8398
+0.0198 (2.41%)
After-hours: Nov 20, 2026, 7:58 PM EST
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
10.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 31.75M |
| Bolt Biotherapeutics | 4.70M |
| Seres Therapeutics | 2.13M |
| Neuphoria Therapeutics | 1.17M |
| Allarity Therapeutics | 350.00K |
| BioCardia | 3.00K |
GUTS News
- 8 days ago - Fractyl Health price target lowered to $4 from $5 at Craig-Hallum - TheFly
- 9 days ago - Fractyl Health price target raised to $40 from $39 at Canaccord - TheFly
- 9 days ago - Fractyl Health target adjusted to $24 from $8 at H.C. Wainwright - TheFly
- 9 days ago - Fractyl Health reports Q3 GAAP EPS ($1.07), consensus ($1.20) - TheFly
- 9 days ago - Fractyl Health Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Fractyl Health Earnings release: Q3 2026 - Filings
- 9 days ago - Fractyl Health Quarterly report: Q3 2026 - Filings
- 9 days ago - Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates - GlobeNewsWire